CPIX
Cumberland Pharmaceuticals Inc
7.60$
-5.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 13.7% | 14.8% | 18.0% | 17.9% | 18.1% | 21.6% | 23.1% | 24.5% | 21.7% | 15.3% | 17.4% | 15.0% | |
| 86.3% | 85.2% | 82.0% | 82.1% | 81.9% | 78.4% | 76.9% | 75.5% | 78.3% | 84.7% | 82.6% | 85.0% | |
| 9.2% | 11.5% | 9.7% | 9.5% | 18.0% | 20.0% | 15.4% | 15.8% | 15.9% | 14.8% | 12.7% | 12.5% | |
| 22.8% | 22.7% | 25.9% | 24.4% | 25.5% | 29.0% | 27.2% | 27.2% | 24.2% | 26.9% | 29.4% | 26.8% | |
| 76.7% | 81.9% | 86.3% | 92.0% | 100.0% | 105.4% | 93.9% | 96.8% | 91.9% | 108.8% | 99.6% | 91.3% | |
| 9.6% | -3.3% | -4.3% | -9.9% | -18.1% | -27.0% | -17.0% | -21.3% | -13.6% | -24.2% | -17.0% | -6.3% | |
| 0.2% | 0.2% | 0.3% | 0.2% | 0.5% | 0.7% | 0.7% | 0.3% | 1.4% | 1.7% | 1.6% | 1.1% | |
| 10.1% | 3.7% | -4.0% | -9.4% | -17.2% | -27.0% | -17.5% | -15.5% | -13.3% | -15.9% | -17.1% | -6.3% | |
| 3.7% | 1.7% | -1.0% | 10.1% | 0.0% | -0.2% | 0.1% | 0.1% | 0.2% | 0.1% | -0.1% | 0.1% | |
| 6.6% | 2.2% | -2.9% | -19.4% | -17.1% | -10.3% | -8.9% | -9.7% | -13.3% | -15.9% | -17.1% | -6.4% | |
| 15.5% | 10.6% | 3.5% | -2.8% | -20.1% | -13.5% | -4.2% | -2.4% | 0.8% | 6.3% | 0.5% | 6.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.